These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18599602)

  • 1. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    J Pharmacol Exp Ther; 2007 Nov; 323(2):499-507. PubMed ID: 17726156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vesicular monoamine transporter 2 regulates the sensitivity of rat dopaminergic neurons to disturbed cytosolic dopamine levels.
    Vergo S; Johansen JL; Leist M; Lotharius J
    Brain Res; 2007 Dec; 1185():18-32. PubMed ID: 18028884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.
    Goldstein DS; Sullivan P; Cooney A; Jinsmaa Y; Kopin IJ; Sharabi Y
    J Neurochem; 2015 Apr; 133(1):14-25. PubMed ID: 25645689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JNK inhibition of VMAT2 contributes to rotenone-induced oxidative stress and dopamine neuron death.
    Choi WS; Kim HW; Xia Z
    Toxicology; 2015 Feb; 328():75-81. PubMed ID: 25496994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
    Qin J; Wu M; Yu S; Gao X; Zhang J; Dong X; Ji J; Zhang Y; Zhou L; Zhang Q; Ding F
    Toxicol Lett; 2015 Nov; 238(3):70-82. PubMed ID: 26276080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP depletion does not account for apoptosis induced by inhibition of mitochondrial electron transport chain in human dopaminergic cells.
    Watabe M; Nakaki T
    Neuropharmacology; 2007 Feb; 52(2):536-41. PubMed ID: 17027047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
    Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T
    J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of Ca2+ signaling in rotenone-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Wang XJ; Xu JX
    Neurosci Lett; 2005 Mar; 376(2):127-32. PubMed ID: 15698934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
    Jalewa J; Sharma MK; Hölscher C
    J Neurochem; 2016 Oct; 139(1):55-67. PubMed ID: 27412483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of melatonin on rotenone plus Ca2+-induced mitochondrial oxidative stress and PC12 cell death.
    Sousa SC; Castilho RF
    Antioxid Redox Signal; 2005; 7(9-10):1110-6. PubMed ID: 16115015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitration of soluble proteins in organotypic culture models of Parkinson's disease.
    Larsen TR; Söderling AS; Caidahl K; Roepstorff P; Gramsbergen JB
    Neurochem Int; 2008 Feb; 52(3):487-94. PubMed ID: 17900761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Puerarin protects dopaminergic neurons in Parkinson's disease models.
    Zhang X; Xiong J; Liu S; Wang L; Huang J; Liu L; Yang J; Zhang G; Guo K; Zhang Z; Wu P; Wang D; Lin Z; Xiong N; Wang T
    Neuroscience; 2014 Nov; 280():88-98. PubMed ID: 25218963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of c-Jun N-terminal protein kinase is a common mechanism underlying paraquat- and rotenone-induced dopaminergic cell apoptosis.
    Klintworth H; Newhouse K; Li T; Choi WS; Faigle R; Xia Z
    Toxicol Sci; 2007 May; 97(1):149-62. PubMed ID: 17324951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
    Leng A; Feldon J; Ferger B
    Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10.
    Moon Y; Lee KH; Park JH; Geum D; Kim K
    J Neurochem; 2005 Jun; 93(5):1199-208. PubMed ID: 15934940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.
    Sherer TB; Betarbet R; Stout AK; Lund S; Baptista M; Panov AV; Cookson MR; Greenamyre JT
    J Neurosci; 2002 Aug; 22(16):7006-15. PubMed ID: 12177198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.
    Xiong N; Xiong J; Khare G; Chen C; Huang J; Zhao Y; Zhang Z; Qiao X; Feng Y; Reesaul H; Zhang Y; Sun S; Lin Z; Wang T
    PLoS One; 2011; 6(6):e20677. PubMed ID: 21677777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.